193 related articles for article (PubMed ID: 33556568)
21. Synthesis and biological evaluation of naphthoquinone phenacylimidazolium derivatives.
Yuan J; Liu Z; Zhang Z; Yan D; Zhang W
Bioorg Med Chem Lett; 2021 Jun; 41():127977. PubMed ID: 33766771
[TBL] [Abstract][Full Text] [Related]
22. Synthesis of Spirooxindole-O-Naphthoquinone-Tetrazolo[1,5-a]Pyrimidine Hybrids as Potential Anticancer Agents.
Wu L; Liu Y; Li Y
Molecules; 2018 Sep; 23(9):. PubMed ID: 30213123
[TBL] [Abstract][Full Text] [Related]
23. Synthesis and cytotoxicity evaluation of novel podophyllotoxin derivatives.
Chengniu W; Zhonghua W; Yu Z; Chunyan N; Xiaodong Z; Li Z
Arch Pharm (Weinheim); 2011 Nov; 344(11):735-40. PubMed ID: 21887802
[TBL] [Abstract][Full Text] [Related]
24. Synthesis of new 9-hydroxy-α- and 7-hydroxy-β-pyran naphthoquinones and cytotoxicity against cancer cell lines.
da Rocha DR; de Souza AC; Resende JA; Santos WC; dos Santos EA; Pessoa C; de Moraes MO; Costa-Lotufo LV; Montenegro RC; Ferreira VF
Org Biomol Chem; 2011 Jun; 9(11):4315-22. PubMed ID: 21487631
[TBL] [Abstract][Full Text] [Related]
25. Target ROS to induce apoptosis and cell cycle arrest by 5,7-dimethoxy-1,4-naphthoquinone derivative.
Li K; Wang B; Zheng L; Yang K; Li Y; Hu M; He D
Bioorg Med Chem Lett; 2018 Feb; 28(3):273-277. PubMed ID: 29305189
[TBL] [Abstract][Full Text] [Related]
26. Multicomponent assembly of 4-aza-podophyllotoxins: A fast entry to highly selective and potent anti-leukemic agents.
Jeedimalla N; Flint M; Smith L; Haces A; Minond D; Roche SP
Eur J Med Chem; 2015 Dec; 106():167-79. PubMed ID: 26547055
[TBL] [Abstract][Full Text] [Related]
27. The ester derivatives obtained by C-ring modification of podophyllotoxin induce apoptosis and inhibited proliferation in PC-3M cells via down-regulation of PI3K/Akt signaling pathway.
Zhao Y; Li D; Wei M; Du R; Yan Z
Bioorg Med Chem Lett; 2021 Aug; 46():128174. PubMed ID: 34098082
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and biological evaluation of novel podophyllotoxin analogs as antitumor agents.
Zhang ZH; Zhang LM; Luo G; Zhang S; Chen H; Zhou J
J Asian Nat Prod Res; 2014; 16(5):527-34. PubMed ID: 24824554
[TBL] [Abstract][Full Text] [Related]
29. Synthesis and anticancer activity of dimeric podophyllotoxin derivatives.
Zi CT; Yang L; Xu FQ; Dong FW; Yang D; Li Y; Ding ZT; Zhou J; Jiang ZH; Hu JM
Drug Des Devel Ther; 2018; 12():3393-3406. PubMed ID: 30349193
[TBL] [Abstract][Full Text] [Related]
30. Design, synthesis, and biological testing of 4beta-[(4-substituted)-1,2,3-triazol-1-yl]podophyllotoxin analogues as antitumor agents.
Reddy PB; Paul DV; Agrawal SK; Saxena AK; Kumar HM; Qazi GN
Arch Pharm (Weinheim); 2008 Feb; 341(2):126-31. PubMed ID: 18214838
[TBL] [Abstract][Full Text] [Related]
31. Synthesis of hybrid 4-deoxypodophyllotoxin-5-fluorouracil compounds that inhibit cellular migration and induce cell cycle arrest.
Guan XW; Xu XH; Feng SL; Tang ZB; Chen SW; Hui L
Bioorg Med Chem Lett; 2016 Mar; 26(6):1561-1566. PubMed ID: 26873416
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and anticancer activity of dichloroplatinum(II) complexes of podophyllotoxin.
Liu X; Zhang LL; Xu XH; Hui L; Zhang JB; Chen SW
Bioorg Med Chem Lett; 2013 Jul; 23(13):3780-4. PubMed ID: 23711918
[TBL] [Abstract][Full Text] [Related]
33. Synthesis and Biological Evaluation of New Naphthoquinones Derivatives.
Ourhzif EM; Decombat C; Abrunhosa-Thomas I; Delort L; Khouili M; Akssira M; Caldefie-Chezet F; Chalard P; Troin Y
Curr Org Synth; 2020; 17(3):224-229. PubMed ID: 32091341
[TBL] [Abstract][Full Text] [Related]
34. Novel 1,4-naphthoquinone-based sulfonamides: Synthesis, QSAR, anticancer and antimalarial studies.
Pingaew R; Prachayasittikul V; Worachartcheewan A; Nantasenamat C; Prachayasittikul S; Ruchirawat S; Prachayasittikul V
Eur J Med Chem; 2015 Oct; 103():446-59. PubMed ID: 26397393
[TBL] [Abstract][Full Text] [Related]
35. Synthesis and biological evaluation of novel benzo[a]pyridazino[3,4-c]phenazine derivatives.
Le-Nhat-Thuy G; Dang Thi TA; Nguyen Thi QG; Hoang Thi P; Nguyen TA; Nguyen HT; Nguyen Thi TH; Nguyen HS; Nguyen TV
Bioorg Med Chem Lett; 2021 Jul; 43():128054. PubMed ID: 33895275
[TBL] [Abstract][Full Text] [Related]
36. Synthesis of novel 1,2-bis-quinolinyl-1,4-naphthoquinones: ERK2 inhibition, cytotoxicity and molecular docking studies.
Aly AA; El-Sheref EM; Bakheet MEM; Mourad MAE; Brown AB; Bräse S; Nieger M; Ibrahim MAA
Bioorg Chem; 2018 Dec; 81():700-712. PubMed ID: 30268050
[TBL] [Abstract][Full Text] [Related]
37. 4β-[(4-Alkyl)-1,2,3-triazol-1-yl] podophyllotoxins as anticancer compounds: design, synthesis and biological evaluation.
Reddy DM; Srinivas J; Chashoo G; Saxena AK; Sampath Kumar HM
Eur J Med Chem; 2011 Jun; 46(6):1983-91. PubMed ID: 21477899
[TBL] [Abstract][Full Text] [Related]
38. A convergent synthesis of alkyne-azide cycloaddition derivatives of 4-α,β-2-propyne podophyllotoxin depicting potent cytotoxic activity.
Zilla MK; Nayak D; Vishwakarma RA; Sharma PR; Goswami A; Ali A
Eur J Med Chem; 2014 Apr; 77():47-55. PubMed ID: 24607588
[TBL] [Abstract][Full Text] [Related]
39. Design, synthesis and anticancer activity of naphthoquinone derivatives.
Shen XB; Wang Y; Han XZ; Sheng LQ; Wu FF; Liu X
J Enzyme Inhib Med Chem; 2020 Dec; 35(1):773-785. PubMed ID: 32200656
[TBL] [Abstract][Full Text] [Related]
40. Design and synthesis of piperazine acetate podophyllotoxin ester derivatives targeting tubulin depolymerization as new anticancer agents.
Sun WX; Ji YJ; Wan Y; Han HW; Lin HY; Lu GH; Qi JL; Wang XM; Yang YH
Bioorg Med Chem Lett; 2017 Sep; 27(17):4066-4074. PubMed ID: 28757065
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
